Janus Henderson Group PLC Sells 152,992 Shares of HCA Healthcare, Inc. $HCA

Janus Henderson Group PLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,089,890 shares of the company’s stock after selling 152,992 shares during the quarter. Janus Henderson Group PLC’s holdings in HCA Healthcare were worth $508,821,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Nordea Investment Management AB increased its position in shares of HCA Healthcare by 11.2% during the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after acquiring an additional 108,849 shares in the last quarter. Hudson Bay Capital Management LP increased its position in shares of HCA Healthcare by 154.5% during the third quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock valued at $2,000,000 after acquiring an additional 2,849 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its position in shares of HCA Healthcare by 6.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after acquiring an additional 3,724 shares in the last quarter. Advisors Capital Management LLC boosted its holdings in HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after purchasing an additional 2,604 shares during the last quarter. Finally, CWA Asset Management Group LLC boosted its holdings in HCA Healthcare by 1,062.4% in the fourth quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after purchasing an additional 8,733 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of several research reports. Mizuho raised their target price on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Robert W. Baird dropped their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. UBS Group lifted their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research note on Monday, February 23rd. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Fifteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $506.14.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $387.87 on Thursday. The stock has a market cap of $86.05 billion, a price-to-earnings ratio of 13.34, a price-to-earnings-growth ratio of 1.26 and a beta of 1.12. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The firm has a 50-day moving average of $424.54 and a two-hundred day moving average of $470.67.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period last year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.